These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11814469)

  • 1. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus.
    Hsu RM; Devaraj S; Jialal I
    Clin Chim Acta; 2002 Mar; 317(1-2):145-50. PubMed ID: 11814469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
    Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
    Tsai WC; Li YH; Chao TH; Chen JH
    J Formos Med Assoc; 2002 Oct; 101(10):681-4. PubMed ID: 12517040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status.
    Brizzi P; Tonolo G; Bertrand G; Carusillo F; Severino C; Maioli M; Malaguarnera L; Musumeci S
    Clin Chem Lab Med; 2004 Feb; 42(2):164-70. PubMed ID: 15061355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
    Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.
    Leinonen JS; Rantalaiho V; Laippala P; Wirta O; Pasternack A; Alho H; Jaakkola O; Ylä-Herttuala S; Koivula T; Lehtimäki T
    Free Radic Res; 1998 Aug; 29(2):137-41. PubMed ID: 9790515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.
    Bellomo G; Maggi E; Poli M; Agosta FG; Bollati P; Finardi G
    Diabetes; 1995 Jan; 44(1):60-6. PubMed ID: 7813815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-density lipoprotein (LDL) antigen source on an enzyme-linked immunosorbent assay for autoantibodies against oxidized LDL.
    Craig WY; Raytcheva SE; Poulin SE; Ritchie RF
    Ann Clin Biochem; 1999 May; 36 ( Pt 3)():333-9. PubMed ID: 10376075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia.
    Hulthe J; Wikstrand J; Lidell A; Wendelhag I; Hansson GK; Wiklund O
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1203-11. PubMed ID: 9714126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL.
    Swets BP; Brouwer DA; Tervaert JW
    Clin Exp Immunol; 2001 Apr; 124(1):163-7. PubMed ID: 11359456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cameroonian professional soccer players and risk of atherosclerosis.
    Nansseu JR; Ama Moor VJ; Takam RDM; Zing-Awona B; Azabji-Kenfack M; Tankeu F; Tchoula CM; Moukette BM; Ngogang JY
    BMC Res Notes; 2017 Jun; 10(1):186. PubMed ID: 28577561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.
    Devaraj S; Jialal I
    Circulation; 2000 Jul; 102(2):191-6. PubMed ID: 10889130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
    González M; Rojas N; Durán D; Schade A; Campos R; Milos C
    Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients.
    El-Bassiouni EA; Helmy MH; El-Zoghby SM; El-Nabi Kamel MA; Hosny RM
    Br J Biomed Sci; 2007; 64(3):109-16. PubMed ID: 17910279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.